EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 308 filers reported holding EXELIXIS INC in Q2 2018. The put-call ratio across all filers is 0.32 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,932 | +153.5% | 175,000 | +169.2% | 1.53% | +281.8% |
| Q1 2024 | $1,551 | -67.5% | 65,000 | -74.0% | 0.40% | -54.3% |
| Q2 2023 | $4,778 | -99.6% | 250,000 | +293.5% | 0.88% | +733.3% |
| Q4 2019 | $1,119,000 | +3.2% | 63,526 | +3.6% | 0.10% | -1.9% |
| Q3 2019 | $1,084,000 | -63.7% | 61,318 | -56.2% | 0.11% | -64.8% |
| Q2 2019 | $2,989,000 | -56.8% | 139,860 | -51.9% | 0.30% | -41.4% |
| Q1 2019 | $6,921,000 | +133.3% | 290,792 | +92.8% | 0.52% | +126.6% |
| Q4 2018 | $2,967,000 | +291.9% | 150,832 | +253.2% | 0.23% | +487.2% |
| Q3 2018 | $757,000 | -17.6% | 42,703 | 0.0% | 0.04% | -17.0% |
| Q2 2018 | $919,000 | -2.9% | 42,703 | 0.0% | 0.05% | -14.5% |
| Q1 2018 | $946,000 | – | 42,703 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 11,275,871 | $254,722,000 | 71.55% |
| GREAT POINT PARTNERS LLC | 1,201,100 | $27,133,000 | 5.61% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 886,534 | $20,027,000 | 5.30% |
| Sargent Investment Group, LLC | 498,350 | $11,258,000 | 2.96% |
| CAPITAL MANAGEMENT CORP /VA | 311,660 | $7,040,000 | 1.57% |
| EULAV Asset Management | 2,460,000 | $55,571,000 | 1.49% |
| CM Management, LLC | 80,000 | $1,807,000 | 1.34% |
| Integral Health Asset Management, LLC | 200,000 | $4,518,000 | 1.29% |
| FARALLON CAPITAL MANAGEMENT LLC | 10,750,000 | $242,843,000 | 1.21% |
| Sofinnova Investments, Inc. | 839,181 | $18,957,000 | 1.14% |